Biljana Rizoska

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Philip G. Conaghan, M.A. Bowes, Sarah R. Kingsbury et al. · Annals of Internal Medicine · 2019 · 141 citations

Medicine, Orthopaedic Surgery, Pharmacotherapy +16

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Erik Lindström, Biljana Rizoska, Karin Tunblad et al. · Journal of Translational Medicine · 2018 · 81 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Erik Lindström, Biljana Rizoska, Ian Henderson et al. · Journal of Translational Medicine · 2018 · 41 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacokinetics +17

Selective Cathepsin S Inhibition with MIV-247 Attenuates Mechanical Allodynia and Enhances the Antiallodynic Effects of Gabapentin and Pregabalin in a Mouse Model of Neuropathic Pain

Ellen Hewitt, Thomas Pitcher, Biljana Rizoska et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 39 citations

Medicine, Pharmacology, Pharmacotherapy +17

The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia

Dana Yehudai, Sanduni U. Liyanage, Rose Hurren et al. · Haematologica · 2018 · 30 citations · Full text

Life Sciences, Cell Biology, Oncology +14